HEMATOLOGY STAINING

The Defense Logistics Agency awarded CENMED ENTERPRISES INC (CAGE 1WAS9) a contract valued at $175.00 on July 20, 2026, under solicitation SPE2DS-26-T-222C, for the provision of HEMATOLOGY STAINING with NSN 6550016592654, specifically the Fisher Scientific product P/N 22-122911. The item is classified as a Class I medical device regulated by the FDA under regulation 864.1850 and must comply with FDA requirements for registration, labeling, and good manufacturing practices, although a 510(k) submission is not required. Delivery must occur within 20 days after order placement, with performance at Tripler AMC in Honolulu, Hawaii, 96859-5000; offers are to be submitted based on FOB Origin despite the contract indicating OTHER delivery terms. The contract incorporates extensive Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including mandatory requirements such as Safeguarding Covered Defense Information and Cyber Incident Reporting (252.204-7012), NIST SP 800-171 DOD Assessment Requirements (252.240-7997), Combating Trafficking in Persons (52.222-50), and prohibitions on covered defense telecommunications equipment (252.204-7018). Deviations apply to several clauses related to System for Award Management registration, maintenance, and subcontracting, all effective February 2026. Packaging must adhere to MIL-STD-2073-1E and DLA’s RP001 standards, with unit containers sealed to protect contents and shipping containers suitable for commercial carrier transport. Labeling must follow Medical Marking Standard No. 1 (MMS No. 1), superseding MIL-STD-129, and must include the date of manufacture, expiration or retest date, and contract/lot number. Shelf-life markings must comply with the latest revision of MMS1C. Destination inspection is required under FAR 52.246-2, and non-accepted supplies must have government identification removed per RQ011. The contractor must use WAWF for electronic invoicing and receiving reports, maintaining an